CSL call for breakthrough medicine translational research proposals – CSL funding available
Could your biological or bioinformatics research lead to an antibody drug, cell- or gene-based therapy if you had the right translation partner? Could it lead to a breakthrough medicine for an autoimmune or inflammatory disease, bleeding or coagulation disorder, or rare disease? If yes, then attend the Industry Connect event to hear from CSL visitors and UniQuest how to submit a brief Concept Proposal for project funding from CSL.
CSL speakers include:
Dr Andrew Nash, Senior Vice President for Research
Dr Andrea Douglas, VP, R&D Strategy, Portfolio & Licensing
Dr Martin Pearse, Director New Product Opportunity Sourcing
Attend the CSL Industry Connect event on Tuesday 9 August from 11am-12pm at the IMB small seminar room 3.146, Queensland Bioscience Precinct.
For more information contact Dr Craig Belcher on ext 54037 or email@example.com.